379 related articles for article (PubMed ID: 25434007)
1. A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder.
Duan J; Shi J; Fiorentino A; Leites C; Chen X; Moy W; Chen J; Alexandrov BS; Usheva A; He D; Freda J; O'Brien NL; ; ; McQuillin A; Sanders AR; Gershon ES; DeLisi LE; Bishop AR; Gurling HM; Pato MT; Levinson DF; Kendler KS; Pato CN; Gejman PV
Am J Hum Genet; 2014 Dec; 95(6):744-53. PubMed ID: 25434007
[TBL] [Abstract][Full Text] [Related]
2. Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci.
Forrest MP; Zhang H; Moy W; McGowan H; Leites C; Dionisio LE; Xu Z; Shi J; Sanders AR; Greenleaf WJ; Cowan CA; Pang ZP; Gejman PV; Penzes P; Duan J
Cell Stem Cell; 2017 Sep; 21(3):305-318.e8. PubMed ID: 28803920
[TBL] [Abstract][Full Text] [Related]
3. A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression.
Warburton A; Breen G; Bubb VJ; Quinn JP
Schizophr Bull; 2016 Jul; 42(4):1003-8. PubMed ID: 26429811
[TBL] [Abstract][Full Text] [Related]
4. Identification and Potential Regulatory Properties of Evolutionary Conserved Regions (ECRs) at the Schizophrenia-Associated MIR137 Locus.
Gianfrancesco O; Griffiths D; Myers P; Collier DA; Bubb VJ; Quinn JP
J Mol Neurosci; 2016 Oct; 60(2):239-47. PubMed ID: 27525637
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide schizophrenia variant at MIR137 does not impact white matter microstructure in healthy participants.
Kelly S; Morris DW; Mothersill O; Rose EJ; Fahey C; O'Brien C; O'Hanlon E; Gill M; Corvin AP; Donohoe G
Neurosci Lett; 2014 Jun; 574():6-10. PubMed ID: 24820543
[TBL] [Abstract][Full Text] [Related]
6. Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation.
Avramopoulos D; Pearce BD; McGrath J; Wolyniec P; Wang R; Eckart N; Hatzimanolis A; Goes FS; Nestadt G; Mulle J; Coneely K; Hopkins M; Ruczinski I; Yolken R; Pulver AE
PLoS One; 2015; 10(3):e0116696. PubMed ID: 25781172
[TBL] [Abstract][Full Text] [Related]
7. Novel functional variants at the GWAS-implicated loci might confer risk to major depressive disorder, bipolar affective disorder and schizophrenia.
Bryzgalov LO; Korbolina EE; Brusentsov II; Leberfarb EY; Bondar NP; Merkulova TI
BMC Neurosci; 2018 Apr; 19(Suppl 1):22. PubMed ID: 29745862
[TBL] [Abstract][Full Text] [Related]
8. How might ZNF804A variants influence risk for schizophrenia and bipolar disorder? A literature review, synthesis, and bioinformatic analysis.
Hess JL; Glatt SJ
Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):28-40. PubMed ID: 24123948
[TBL] [Abstract][Full Text] [Related]
9. The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis.
Vogel BO; Lett TA; Erk S; Mohnke S; Wackerhagen C; Brandl EJ; Romanczuk-Seiferth N; Otto K; Schweiger JI; Tost H; Nöthen MM; Rietschel M; Degenhardt F; Witt SH; Meyer-Lindenberg A; Heinz A; Walter H
Schizophr Res; 2018 May; 195():190-196. PubMed ID: 28958479
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies five new schizophrenia loci.
Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium
Nat Genet; 2011 Sep; 43(10):969-76. PubMed ID: 21926974
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.
Green MJ; Cairns MJ; Wu J; Dragovic M; Jablensky A; Tooney PA; Scott RJ; Carr VJ;
Mol Psychiatry; 2013 Jul; 18(7):774-80. PubMed ID: 22733126
[TBL] [Abstract][Full Text] [Related]
12. A screen of 1,049 schizophrenia and 30 Alzheimer's-associated variants for regulatory potential.
Myint L; Wang R; Boukas L; Hansen KD; Goff LA; Avramopoulos D
Am J Med Genet B Neuropsychiatr Genet; 2020 Jan; 183(1):61-73. PubMed ID: 31503409
[TBL] [Abstract][Full Text] [Related]
13. Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder.
Whalley HC; Papmeyer M; Romaniuk L; Sprooten E; Johnstone EC; Hall J; Lawrie SM; Evans KL; Blumberg HP; Sussmann JE; McIntosh AM
Neuropsychopharmacology; 2012 Nov; 37(12):2720-9. PubMed ID: 22850735
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder.
Harvey PD; Sun N; Bigdeli TB; Fanous AH; Aslan M; Malhotra AK; Lu Q; Hu Y; Li B; Chen Q; Mane S; Miller P; Rajeevan N; Sayward F; Cheung KH; Li Y; Greenwood TA; Gur RE; Braff DL; ; Brophy M; Pyarajan S; O'Leary TJ; Gleason T; Przygodszki R; Muralidhar S; Gaziano JM; Concato J; Zhao H; Siever LJ
Am J Med Genet B Neuropsychiatr Genet; 2020 Apr; 183(3):181-194. PubMed ID: 31872970
[TBL] [Abstract][Full Text] [Related]
15. Novel brain expressed RNA identified at the MIR137 schizophrenia-associated locus.
Gianfrancesco O; Warburton A; Collier DA; Bubb VJ; Quinn JP
Schizophr Res; 2017 Jun; 184():109-115. PubMed ID: 27913161
[TBL] [Abstract][Full Text] [Related]
16. Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF804A in human dorsolateral prefrontal cortex.
Guella I; Sequeira A; Rollins B; Morgan L; Myers RM; Watson SJ; Akil H; Bunney WE; Delisi LE; Byerley W; Vawter MP
Schizophr Res; 2014 Jan; 152(1):111-6. PubMed ID: 24315717
[TBL] [Abstract][Full Text] [Related]
17.
Liu S; Li A; Liu Y; Li J; Wang M; Sun Y; Qin W; Yu C; Jiang T; Liu B
Psychol Med; 2020 Jul; 50(9):1510-1518. PubMed ID: 31239006
[TBL] [Abstract][Full Text] [Related]
18. Loci with genome-wide associations with schizophrenia in the Han Chinese population.
Li Z; Xiang Y; Chen J; Li Q; Shen J; Liu Y; Li W; Xing Q; Wang Q; Wang L; Feng G; He L; Zhao X; Shi Y
Br J Psychiatry; 2015 Dec; 207(6):490-4. PubMed ID: 26206863
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the miR-708 gene and its binding targets in bipolar disorder.
Fiorentino A; O'Brien NL; Sharp SI; Curtis D; Bass NJ; McQuillin A
Bipolar Disord; 2016 Dec; 18(8):650-656. PubMed ID: 27864917
[TBL] [Abstract][Full Text] [Related]
20. Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.
Pedrosa E; Stefanescu R; Margolis B; Petruolo O; Lo Y; Nolan K; Novak T; Stopkova P; Lachman HM
Schizophr Res; 2008 Jul; 102(1-3):210-9. PubMed ID: 18508241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
